Report Detail
Global Darbepoetin Alfa Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM2974972 |
- 18 February, 2019 |
- Global |
- 117 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
Scope of the Report:
The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.
Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.
North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.
The worldwide market for Darbepoetin Alfa is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Darbepoetin Alfa in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Epogen
Procrit
Aranesp
Others
Market Segment by Applications, can be divided into
Patients with Chronic Kidney Disease
Patients with Cancer
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Darbepoetin Alfa product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Darbepoetin Alfa, with price, sales, revenue and global market share of Darbepoetin Alfa in 2017 and 2018.
Chapter 3, the Darbepoetin Alfa competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Darbepoetin Alfa breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Darbepoetin Alfa market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Darbepoetin Alfa sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Darbepoetin Alfa Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Epogen
- 1.2.2 Procrit
- 1.2.3 Aranesp
- 1.2.4 Others
- 1.3 Market Analysis by Applications
- 1.3.1 Patients with Chronic Kidney Disease
- 1.3.2 Patients with Cancer
- 1.3.3 Others
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Amgen
- 2.1.1 Business Overview
- 2.1.2 Darbepoetin Alfa Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Amgen Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Johnson & Johnson
- 2.2.1 Business Overview
- 2.2.2 Darbepoetin Alfa Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Johnson & Johnson Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Kyowa Hakko Kirin
- 2.3.1 Business Overview
- 2.3.2 Darbepoetin Alfa Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Kyowa Hakko Kirin Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Novartis
- 2.4.1 Business Overview
- 2.4.2 Darbepoetin Alfa Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Novartis Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 3SBio
- 2.5.1 Business Overview
- 2.5.2 Darbepoetin Alfa Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 3SBio Darbepoetin Alfa Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Darbepoetin Alfa Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Darbepoetin Alfa Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Darbepoetin Alfa Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Darbepoetin Alfa Manufacturer Market Share in 2018
- 3.3.2 Top 6 Darbepoetin Alfa Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Darbepoetin Alfa Market Analysis by Regions
- 4.1 Global Darbepoetin Alfa Sales, Revenue and Market Share by Regions
- 4.1.1 Global Darbepoetin Alfa Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Darbepoetin Alfa Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 4.3 Europe Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 4.5 South America Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Darbepoetin Alfa Sales and Growth Rate (2014-2019)
5 North America Darbepoetin Alfa by Country
- 5.1 North America Darbepoetin Alfa Sales, Revenue and Market Share by Country
- 5.1.1 North America Darbepoetin Alfa Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Darbepoetin Alfa Revenue and Market Share by Country (2014-2019)
- 5.2 United States Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 5.3 Canada Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 5.4 Mexico Darbepoetin Alfa Sales and Growth Rate (2014-2019)
6 Europe Darbepoetin Alfa by Country
- 6.1 Europe Darbepoetin Alfa Sales, Revenue and Market Share by Country
- 6.1.1 Europe Darbepoetin Alfa Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Darbepoetin Alfa Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 6.3 UK Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 6.4 France Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 6.5 Russia Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 6.6 Italy Darbepoetin Alfa Sales and Growth Rate (2014-2019)
7 Asia-Pacific Darbepoetin Alfa by Country
- 7.1 Asia-Pacific Darbepoetin Alfa Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Darbepoetin Alfa Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Darbepoetin Alfa Revenue and Market Share by Country (2014-2019)
- 7.2 China Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 7.3 Japan Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 7.4 Korea Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 7.5 India Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Darbepoetin Alfa Sales and Growth Rate (2014-2019)
8 South America Darbepoetin Alfa by Country
- 8.1 South America Darbepoetin Alfa Sales, Revenue and Market Share by Country
- 8.1.1 South America Darbepoetin Alfa Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Darbepoetin Alfa Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 8.3 Argentina Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 8.4 Colombia Darbepoetin Alfa Sales and Growth Rate (2014-2019)
9 Middle East and Africa Darbepoetin Alfa by Countries
- 9.1 Middle East and Africa Darbepoetin Alfa Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Darbepoetin Alfa Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Darbepoetin Alfa Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 9.3 Turkey Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 9.4 Egypt Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Darbepoetin Alfa Sales and Growth Rate (2014-2019)
- 9.6 South Africa Darbepoetin Alfa Sales and Growth Rate (2014-2019)
10 Global Darbepoetin Alfa Market Segment by Type
- 10.1 Global Darbepoetin Alfa Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Darbepoetin Alfa Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Darbepoetin Alfa Revenue and Market Share by Type (2014-2019)
- 10.2 Epogen Sales Growth and Price
- 10.2.1 Global Epogen Sales Growth (2014-2019)
- 10.2.2 Global Epogen Price (2014-2019)
- 10.3 Procrit Sales Growth and Price
- 10.3.1 Global Procrit Sales Growth (2014-2019)
- 10.3.2 Global Procrit Price (2014-2019)
- 10.4 Aranesp Sales Growth and Price
- 10.4.1 Global Aranesp Sales Growth (2014-2019)
- 10.4.2 Global Aranesp Price (2014-2019)
- 10.5 Others Sales Growth and Price
- 10.5.1 Global Others Sales Growth (2014-2019)
- 10.5.2 Global Others Price (2014-2019)
11 Global Darbepoetin Alfa Market Segment by Application
- 11.1 Global Darbepoetin Alfa Sales Market Share by Application (2014-2019)
- 11.2 Patients with Chronic Kidney Disease Sales Growth (2014-2019)
- 11.3 Patients with Cancer Sales Growth (2014-2019)
- 11.4 Others Sales Growth (2014-2019)
12 Darbepoetin Alfa Market Forecast (2019-2024)
- 12.1 Global Darbepoetin Alfa Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Darbepoetin Alfa Market Forecast by Regions (2019-2024)
- 12.2.1 North America Darbepoetin Alfa Market Forecast (2019-2024)
- 12.2.2 Europe Darbepoetin Alfa Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Darbepoetin Alfa Market Forecast (2019-2024)
- 12.2.4 South America Darbepoetin Alfa Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Darbepoetin Alfa Market Forecast (2019-2024)
- 12.3 Darbepoetin Alfa Market Forecast by Type (2019-2024)
- 12.3.1 Global Darbepoetin Alfa Sales Forecast by Type (2019-2024)
- 12.3.2 Global Darbepoetin Alfa Market Share Forecast by Type (2019-2024)
- 12.4 Darbepoetin Alfa Market Forecast by Application (2019-2024)
- 12.4.1 Global Darbepoetin Alfa Sales Forecast by Application (2019-2024)
- 12.4.2 Global Darbepoetin Alfa Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Darbepoetin Alfa . Industry analysis & Market Report on Darbepoetin Alfa is a syndicated market report, published as Global Darbepoetin Alfa Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Darbepoetin Alfa market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
